Aurobindo Pharma to expand manufacture of generic formulations in France
2026-05-22·via Business News Today: Latest Business News, Finance News
SENSEX 75,415.35
+ 231.99
NIFTY 23,719.30
+ 64.60
CRUDEOIL 9,363.00
+ 21.00
GOLD 158,723.00
-883.00
SILVER 271,698.00
-3,185.00
SENSEX 75,415.35
+ 231.99
NIFTY 23,719.30
+ 64.60
NIFTY 23,719.30
+ 64.60
CRUDEOIL 9,363.00
+ 21.00
CRUDEOIL 9,363.00
+ 21.00
GOLD 158,723.00
-883.00
Agile Pharma BV, a wholly-owned step-down arm of Aurobindo, has incorporated a new subsidiary in France, Arrow Pharma Production SAS, for this
Agile Pharma BV, a wholly-owned step-down subsidiary of Aurobindo Pharma, has incorporated a new wholly-owned subsidiary in France, Arrow Pharma Production SAS.
Agile Pharma is the holding company of Arrow Pharma Production SAS. As Agile is a wholly-owned step-down subsidiary of the Hyderabad-based Aurobindo, Arrow Pharma Production SAS would also become a wholly-owned step-down subsidiary of Aurobindo, the company informed the BSE.
“The object of incorporation Arrow Pharma is to expand the manufacturing of generic formulations in France,’’ the company said.
Published on May 22, 2026
THIS AD SUPPORTS OUR JOURNALISM.
SUBSCRIBE
FOR MINIMAL ADS.
THIS AD SUPPORTS OUR JOURNALISM.
SUBSCRIBE
FOR MINIMAL ADS.